ALLERGY THER. PLC LS-001
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as wel… Read more
Market Cap & Net Worth: ALLERGY THER. PLC LS-001 (HHU)
ALLERGY THER. PLC LS-001 (F:HHU) has a market capitalization of $788.00 Million (€767.68 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #23251 globally and #2535 in its home market, demonstrating a 0.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ALLERGY THER. PLC LS-001's stock price €0.13 by its total outstanding shares 6141439951 (6.14 Billion).
ALLERGY THER. PLC LS-001 Market Cap History: 2020 to 2026
ALLERGY THER. PLC LS-001's market capitalization history from 2020 to 2026. Data shows change from $917.23 Million to $788.00 Million (-3.31% CAGR).
ALLERGY THER. PLC LS-001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ALLERGY THER. PLC LS-001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of HHU by Market Capitalization
Companies near ALLERGY THER. PLC LS-001 in the global market cap rankings as of March 19, 2026.
Key companies related to ALLERGY THER. PLC LS-001 by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
ALLERGY THER. PLC LS-001 Historical Marketcap From 2020 to 2026
Between 2020 and today, ALLERGY THER. PLC LS-001's market cap moved from $917.23 Million to $ 788.00 Million, with a yearly change of -3.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €788.00 Million | +6.84% |
| 2025 | €737.57 Million | +70.80% |
| 2024 | €431.83 Million | +218.60% |
| 2023 | €135.54 Million | -54.26% |
| 2022 | €296.29 Million | -87.82% |
| 2021 | €2.43 Billion | +165.29% |
| 2020 | €917.23 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ALLERGY THER. PLC LS-001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $788.00 Million USD |
| MoneyControl | $788.00 Million USD |
| MarketWatch | $788.00 Million USD |
| marketcap.company | $788.00 Million USD |
| Reuters | $788.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.